MARKET

AMRN

AMRN

Amarin
NASDAQ
15.73
-0.64
-3.91%
Pre Market: 16.01 +0.28 +1.78% 06:57 07/07 EDT
OPEN
16.37
PREV CLOSE
16.37
HIGH
16.46
LOW
15.64
VOLUME
320
TURNOVER
0
52 WEEK HIGH
20.90
52 WEEK LOW
12.96
MARKET CAP
329.84M
P/E (TTM)
-1.0790
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AMRN last week (0629-0703)?
Weekly Report · 1d ago
AstraZeneca's Enhertu Wins EU Nod for HER2-Positive Solid Tumors (Revised)
NASDAQ · 6d ago
Amarin Highlights Recent FDA Approval Of Injectable Apolipoprotein C-III Therapies For Treatment Of Severe Hypertriglyceridemia, Defined As Triglycerides Greater Than Or Equal To 500 mg/dL
Benzinga · 06/30 20:18
Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA® (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape
Barchart · 06/30 15:15
Weekly Report: what happened at AMRN last week (0622-0626)?
Weekly Report · 06/29 09:22
Weekly Report: what happened at AMRN last week (0615-0619)?
Weekly Report · 06/22 09:25
Weekly Report: what happened at AMRN last week (0608-0612)?
Weekly Report · 06/15 09:25
Palisade Bio adds Robert Baltera, Jordan Zwick to board of directors
PUBT · 06/11 12:45
More
About AMRN
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

Webull offers Amarin Corporation PLC stock information, including NASDAQ: AMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMRN stock methods without spending real money on the virtual paper trading platform.